Focue Provides the Latest and Most Up-to-Date News, What You Focus On is What You Get.
⎯ 《 Focue • Com 》

List of All Articles with Tag 'obesity'

"Last hope": Eager Germans are prepared to pay for weight-loss drug
By Ludwig Burger and Maggie Fick FRANKFURT/LONDON Frustrated after countless failed diet and exercise attempts, 41 year-old Jessica
1970-01-01 08:00
Strong U.S. demand eases pressure on Novo to show weight-loss drug's health benefits
Strong U.S. demand eases pressure on Novo to show weight-loss drug's health benefits
By Maggie Fick LONDON Soaring U.S. demand for Novo Nordisk's weight-loss drug has reduced the pressure from investors
1970-01-01 08:00
Biotech firms target weight-loss drugs without Wegovy's side-effects
Biotech firms target weight-loss drugs without Wegovy's side-effects
By Maggie Fick LONDON Weight-loss drug Wegovy helped Rebecca Vogt achieve a major goal - shedding the weight
1970-01-01 08:00
Hold the Ozempic before surgery, US doctors say
Hold the Ozempic before surgery, US doctors say
By Julie Steenhuysen CHICAGO People taking popular diabetes and weight loss drugs such as Novo Nordisk's Ozempic and
1970-01-01 08:00
Analysis-Weight loss drug candidates multiply, spurring hopes of better outcomes, lower costs
Analysis-Weight loss drug candidates multiply, spurring hopes of better outcomes, lower costs
By Deena Beasley SAN DIEGO New data on weight loss drugs that could compete with Novo Nordisk's Wegovy
1970-01-01 08:00
Novo Nordisk says obesity pill leads to 15% weight loss; availability
Novo Nordisk says obesity pill leads to 15% weight loss; availability "to be determined"
By Deena Beasley SAN DIEGO Drugmaker Novo Nordisk on Sunday said a late-stage trial found that a high-dose
1970-01-01 08:00
Experimental Lilly pill, Mounjaro both lead to 15% weight loss in clinical trials
Experimental Lilly pill, Mounjaro both lead to 15% weight loss in clinical trials
By Deena Beasley (Reuters) -In a mid-stage trial, the highest dose of Eli Lilly's experimental pill orforglipron led to 14.7%
1970-01-01 08:00
Britain to explore wider access to weight-loss drugs in two-year pilot
Britain to explore wider access to weight-loss drugs in two-year pilot
By Ludwig Burger and Maggie Fick (Reuters) -The British government will launch a pilot programme to explore how new injectable
1970-01-01 08:00
Weight-loss drug pioneers aim to jump on Wegovy bandwagon
Weight-loss drug pioneers aim to jump on Wegovy bandwagon
By Jennifer Rigby DUBLIN Weight loss drug Wegovy has transformed the obesity market and pharmaceutical companies with existing
1970-01-01 08:00
Novo Nordisk: trial data of oral weight-loss drug comparable to Wegovy
Novo Nordisk: trial data of oral weight-loss drug comparable to Wegovy
By Louise Rasmussen COPENHAGEN (Reuters) -Novo Nordisk said on Monday data from a late-stage trial showed an oral version of
1970-01-01 08:00
Obesity drug brings heart health benefit alongside weight loss - study
Obesity drug brings heart health benefit alongside weight loss - study
By Jennifer Rigby DUBLIN Taking Novo Nordisk’s new obesity drug may help reduce the risk of heart disease
1970-01-01 08:00
Exclusive-Wegovy, other weight loss drugs ‘no silver bullet’, says WHO amid obesity review
Exclusive-Wegovy, other weight loss drugs ‘no silver bullet’, says WHO amid obesity review
By Jennifer Rigby LONDON New highly-effective weight loss drugs such as Novo Nordisk's Wegovy are not a “silver
1970-01-01 08:00
«123»